{
  "pmcid": "4357072",
  "config": {
    "model": "gemini",
    "strategy": "few-shot"
  },
  "usage": {
    "input": 15486,
    "output": 636
  },
  "raw_text": "```json\n{\n  \"extractions\": [\n    {\n      \"outcome\": \"improvement in symptom scores\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": 3.6,\n      \"intervention_standard_deviation\": 0.7,\n      \"comparator_mean\": 3.5,\n      \"comparator_standard_deviation\": 1.0\n    },\n    {\n      \"outcome\": \"reduction in burning sensation\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"continuous\",\n      \"intervention_events\": null,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": null,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": 55.3,\n      \"intervention_standard_deviation\": 22.5,\n      \"comparator_mean\": 45.3,\n      \"comparator_standard_deviation\": 33.5\n    },\n    {\n      \"outcome\": \"reduction in erythematous area\",\n      \"intervention\": \"topical pimecrolimus cream 1%\",\n      \"comparator\": \"triamcinolone acetonide oral paste 0.1%\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 15,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": 15,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    },\n    {\n      \"outcome\": \"reappearance of erythematous areas after 2 months posttreatment\",\n      \"intervention\": \"pimecrolimus\",\n      \"comparator\": \"triamcinolone acetate\",\n      \"outcome_type\": \"binary\",\n      \"intervention_events\": 1,\n      \"intervention_group_size\": 15,\n      \"comparator_events\": 5,\n      \"comparator_group_size\": 15,\n      \"intervention_mean\": null,\n      \"intervention_standard_deviation\": null,\n      \"comparator_mean\": null,\n      \"comparator_standard_deviation\": null\n    }\n  ]\n}\n```",
  "extraction": [
    {
      "outcome": "improvement in symptom scores",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 3.6,
      "intervention_standard_deviation": 0.7,
      "comparator_mean": 3.5,
      "comparator_standard_deviation": 1.0,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in burning sensation",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "continuous",
      "intervention_events": null,
      "intervention_group_size": 15,
      "comparator_events": null,
      "comparator_group_size": 15,
      "intervention_mean": 55.3,
      "intervention_standard_deviation": 22.5,
      "comparator_mean": 45.3,
      "comparator_standard_deviation": 33.5,
      "pmcid": "4357072"
    },
    {
      "outcome": "reduction in erythematous area",
      "intervention": "topical pimecrolimus cream 1%",
      "comparator": "triamcinolone acetonide oral paste 0.1%",
      "outcome_type": "binary",
      "intervention_events": 15,
      "intervention_group_size": 15,
      "comparator_events": 15,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    },
    {
      "outcome": "reappearance of erythematous areas after 2 months posttreatment",
      "intervention": "pimecrolimus",
      "comparator": "triamcinolone acetate",
      "outcome_type": "binary",
      "intervention_events": 1,
      "intervention_group_size": 15,
      "comparator_events": 5,
      "comparator_group_size": 15,
      "intervention_mean": null,
      "intervention_standard_deviation": null,
      "comparator_mean": null,
      "comparator_standard_deviation": null,
      "pmcid": "4357072"
    }
  ]
}